search
insulin
Trends
- 1One Genetic Tweak Could Turn Pancreatic Cells Into Diabetes Treatment▼Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.c
A Wired report says some pancreatic cells are only a single genetic modification away from becoming insulin-producing beta cells, a finding that could open new paths for treating diabetes. Scientists are discussing what the discovery means for regenerative medicine and whether reprogramming existing cells could one day restore insulin function in patients.
- 2Iran faces shortages of 800 medicines amid sanctions and war costs●A Hebrew newspaper reports that US sanctions, inflation, currency shortages, and the costs of war have exacerbated Iran'
A Hebrew newspaper reports that Iran's pharmaceutical crisis has worsened, with shortages affecting roughly 800 types of medication, including drugs for cancer, heart conditions, migraines and insulin. The report attributes the crisis to US sanctions, high inflation, currency shortages and the financial burden of war, leaving patients struggling to obtain essential treatments.
- 3The End of Insulin Injections? Scientists Pursue Needle-Free Medicine▼The End of Insulin Injections? How Scientists Are Making Medicine Needle-Free
National Geographic reports on scientific efforts to replace insulin injections with needle-free alternatives, a change that could affect millions of people with diabetes who rely on daily injections. Researchers are exploring new delivery methods that would remove the need for needles in administering insulin and potentially other medicines.
- 4Israeli startup DreaMed wins FDA nod for insulin-dosing app▼Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes
Israeli medtech startup DreaMed Diabetes has received FDA approval for an app that automatically adjusts insulin doses for people with Type 2 diabetes. The clearance lets the company bring its digital insulin-management tool to American patients, extending technology previously aimed at Type 1 diabetes. The news, reported by Calcalist, is being read as a milestone for Israeli digital health firms seeking US market entry.
- 5Israeli startup wins FDA clearance for injection-based diabetes app▼Israeli startup develops injection-based diabetes app, receives FDA clearance
An Israeli startup has received FDA clearance for an app designed to support people who manage diabetes with insulin injections. The digital tool aims to help patients track and manage their injection-based treatment, and its clearance means it can now be marketed in the United States. The news was reported by The Jerusalem Post and highlights Israel's growing health-tech sector.
- 6Pancreatic Cells One Genetic Tweak From Treating Diabetes●Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https://www.wired.com/story/pancreatic-cell
New research reported by Wired suggests some pancreatic cells could be converted into insulin-producing cells through a single genetic modification, offering a potential new avenue for treating diabetes. The findings point to reprogramming existing cells rather than replacing them, a possibility researchers say could one day change how the disease is managed.
- 7FDA approves Onswik, a once-weekly insulin for type 2 diabetes●The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the s
The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.
- 8
The American Diabetes Association has released new guidance aimed at helping primary care providers use diabetes technology, such as continuous glucose monitors and insulin delivery systems, in everyday patient care. The move reflects how these tools are shifting from specialist settings into general practice, and clinicians are expected to review the recommendations for managing patients with diabetes.
- 9New questions raised in killer nurse Colin Norris case●Murder or medical mix-up? New questions in the case of killer nurse Colin Norris https://www.bbc.co.uk/news/articles/ckg
Fresh scrutiny has emerged over the convictions of Colin Norris, the UK nurse jailed in 2008 for murdering four elderly patients and attempting to kill a fifth in Leeds hospitals. The case hinged on low blood sugar levels as evidence of insulin poisoning, and new reporting is asking whether the deaths could have had natural medical explanations instead, reopening debate over a possible miscarriage of justice.